SBC Medical Group Holdings Inc
SBCUS売上高
$174M
百万USD
営業利益
$67M
百万USD
純利益
$51M
百万USD
ROE
20.5%
最新FY
EPS
$0.50
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2022 | Q2 | - | $-0M | - |
| FY2022 | Q3 | - | $-0M | - |
| FY2022 | FY | - | - | - |
| FY2023 | Q1 | - | $1M | - |
| FY2023 | Q2 | - | $0M | - |
| FY2023 | Q3 | - | $-0M | - |
| FY2023 | FY | - | $0M | - |
| FY2024 | Q1 | - | $-0M | - |
| FY2024 | Q2 | - | $-0M | - |
| FY2024 | Q3 | $53M | $3M | $0.03 |
| FY2024 | FY | $205M | $47M | $0.48 |
| FY2025 | Q1 | $47M | $22M | $0.21 |
| FY2025 | Q2 | $43M | $2M | $0.02 |
| FY2025 | Q3 | $43M | $13M | $0.12 |
| FY2025 | FY | $174M | $51M | $0.50 |
| FY2026 | Q1 | $43M | $11M | $0.11 |
財務データ
| 指標 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| 売上高 | - | - | $205M | $174M |
| 営業利益 | - | $-2M | $70M | $67M |
| 純利益 | - | $0M | $47M | $51M |
| 総資産 | $120M | $21M | $266M | $380M |
| 純資産 | - | - | $195M | $263M |
| 自己資本 | $-3M | $-6M | $195M | $248M |
| 営業CF | - | $-2M | $21M | $25M |
| EPS | - | - | $0.48 | $0.50 |
| BPS | - | - | $1.88 | $2.42 |
| ROE | - | -5.7% | 23.9% | 20.5% |